VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,563 | -10.6% | 504 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $15,175 | -6.9% | 504 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $16,304 | +12.9% | 504 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $14,445 | +20.4% | 504 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $12,000 | -14.3% | 504 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | -26.3% | 504 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $19,000 | +18.8% | 504 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $16,000 | +6.7% | 504 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -11.8% | 504 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | +6.2% | 504 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $16,000 | -30.4% | 504 | -20.0% | 0.00% | -25.0% |
| Q4 2020 | $23,000 | -8.0% | 630 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $25,000 | +8.7% | 630 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $23,000 | – | 630 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |